Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT05109195
What this trial is testing

A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 7
Testing effectiveness (Phase 2)Study completedNCT03030183
What this trial is testing

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Ra Pharmaceuticals 3
Large-scale testing (Phase 3)Study completedNCT02721966
What this trial is testing

Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement

Who this might be right for
Axial Psoratic Arthritis
Novartis Pharmaceuticals 503
Post-approval studies (Phase 4)Study completedNCT01758198
What this trial is testing

Abatacept Post-marketing Clinical Study in Japan

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 405
Large-scale testing (Phase 3)Study completedNCT01961609
What this trial is testing

Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 235
Post-approval studies (Phase 4)Looking for participantsNCT02714634
What this trial is testing

Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide

Who this might be right for
Rheumatoid ArthritisInsufficient Response to Methotrexate or Leflunomide
University Hospital, Strasbourg, France 286
Large-scale testing (Phase 3)UnknownNCT00214656
What this trial is testing

"Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery

Who this might be right for
Myocardial IschemiaBlood Coagulation DisordersCoronary Artery Disease+1 more
Austin Health 40
Large-scale testing (Phase 3)Study completedNCT00422383
What this trial is testing

Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 378
Large-scale testing (Phase 3)Study completedNCT00468546
What this trial is testing

Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 520
Large-scale testing (Phase 3)Study completedNCT00750880
What this trial is testing

An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,681
Testing effectiveness (Phase 2)Study completedNCT01526057
What this trial is testing

A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)

Who this might be right for
Rheumatoid Arthritis
Pfizer 220
Large-scale testing (Phase 3)Ended earlyNCT00406653
What this trial is testing

Abatacept in Patients With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Bristol-Myers Squibb 451
Large-scale testing (Phase 3)Study completedNCT01759030
What this trial is testing

Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biocad 181
Testing effectiveness (Phase 2)WithdrawnNCT01652937
What this trial is testing

BIIB057 in Subjects With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs

Who this might be right for
Rheumatoid Arthritis
Biogen
Testing effectiveness (Phase 2)Study completedNCT04058028
What this trial is testing

Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Amgen 244
Testing effectiveness (Phase 2)Study completedNCT00605735
What this trial is testing

PoC in Rheumatoid Arthritis With Methotrexate

Who this might be right for
Rheumatoid Arthritis, NOS
Bristol-Myers Squibb 121
Large-scale testing (Phase 3)Looking for participantsNCT05076175
What this trial is testing

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Bristol-Myers Squibb 120
Large-scale testing (Phase 3)Looking for participantsNCT06641089
What this trial is testing

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Who this might be right for
Arthritis, Psoriatic
MoonLake Immunotherapeutics AG 600
Not applicableStudy completedNCT01397903
What this trial is testing

Description of Treatment Management of Patients With Major Depressive Disorder and Inadequate Response

Who this might be right for
Major Depressive Disorder
AstraZeneca 545
Testing effectiveness (Phase 2)Looking for participantsNCT07409103
What this trial is testing

Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

Who this might be right for
Active Rheumatoid Arthritis
Elevara Medicines Limited 180
Next Page